STEPHEN THOMPSON - Director
Brandon Capital Partners
Stephen Thompson has 25 years international experience in the life science sector. He is currently a director of Brandon Capital Partners. Prior to moving to Australia he was a director of Apax Partners, a leading international private equity group. Before that, he worked with Cantab Pharmaceuticals, a UK biotechnology company after 10 years as a research immunologist in London and California. Stephen has an honours degree and PhD in immunology and an MBA.
Held Board positions with US companies – Nasdaq list Trinity Biotech, Impedance Cardiology Systems, CDIC for Diagnostics
